Cargando…
Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids
Decay-accelerating factor (DAF) is a 70 kD membrane regulatory protein that prevents the activation of autologous complement on cell surfaces. Using immunohistochemical methods and a radioimmunometric assay based on mAbs to DAF, we found large amounts of membrane-associated DAF antigen on the epithe...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188295/ https://www.ncbi.nlm.nih.gov/pubmed/2434600 |
Ejemplares similares
-
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes
Publicado: (1984) -
Identification of human erythrocyte blood group antigens on decay- accelerating factor (DAF) and an erythrocyte phenotype negative for daf
por: Telen, MJ, et al.
Publicado: (1988) -
The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1
Publicado: (1987) -
Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein
Publicado: (1986) -
The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb
Publicado: (1987)